Pharmacology CMS Practice Test

The main idea here is that uncomplicated acute otitis media in patients without penicillin allergy should be treated with a narrow, reliable antibiotic that covers the usual ear pathogens and reaches good levels in the middle ear. Amoxicillin fits best because of its strong activity against the common culprits—Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Moraxella catarrhalis—combined with excellent oral bioavailability. When given in a high-dose regimen (about 80–90 mg/kg/day, split into two doses, for about 5–10 days), amoxicillin achieves sufficient concentrations in middle ear fluid to treat organisms that may have reduced susceptibility and to reduce treatment failures. It’s also cost-effective and generally well tolerated, making it a practical first choice. The other options are more appropriate in specific scenarios. Cefdinir can be used if amoxicillin cannot be given, but it’s not the preferred first-line due to broader spectrum and other practical considerations. Azithromycin has higher rates of resistance among the usual otitis media pathogens, reducing its effectiveness as first-line therapy. Clindamycin covers some bacteria but lacks reliable activity against non-typeable H. influenzae and Moraxella and carries a higher risk of Clostridioides difficile infection, so it’s not favored as initial therapy.